521 related articles for article (PubMed ID: 22322005)
1. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
[TBL] [Abstract][Full Text] [Related]
2. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
4. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
5. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Zhou P; Zhang S; Wang Y; Yang C; Huang J
J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
[TBL] [Abstract][Full Text] [Related]
6. HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome.
Yang CW; Hung SI; Juo CG; Lin YP; Fang WH; Lu IH; Chen ST; Chen YT
J Allergy Clin Immunol; 2007 Oct; 120(4):870-7. PubMed ID: 17697703
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.
Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC;
Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
Chung WH; Hung SI
J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
[TBL] [Abstract][Full Text] [Related]
9. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Ko TM; Chen YT
Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
12. Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China.
He XJ; Jian LY; He XL; Wu Y; Xu YY; Sun XJ; Miao LY; Zhao LM
Pharmacol Rep; 2013; 65(5):1256-62. PubMed ID: 24399721
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
14. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
15. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
Wu XT; Hu FY; An DM; Yan B; Jiang X; Kwan P; Stefan H; Zhou D
Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
[TBL] [Abstract][Full Text] [Related]
16. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
[TBL] [Abstract][Full Text] [Related]
17. HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis.
Jaruthamsophon K; Tipmanee V; Sangiemchoey A; Sukasem C; Limprasert P
Sci Rep; 2017 Mar; 7():45553. PubMed ID: 28358139
[TBL] [Abstract][Full Text] [Related]
18. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
Neuman MG; Cohen L; Nanau RM; Hwang PA
Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
[TBL] [Abstract][Full Text] [Related]
19. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?
Shi YW; Min FL; Qin B; Zou X; Liu XR; Gao MM; Wang Q; Zhou JQ; Liao WP
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):58-64. PubMed ID: 22348435
[TBL] [Abstract][Full Text] [Related]
20. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
